The State of the Central Labs Market

Q3, 2010

This report contains interviews with 105 central labs decision-makers from North America, Europe, and Asia representing 77 different biopharma companies. Participants provide views to their outsourcing and service provider selection strategies as well as their spending for central labs services. Participants also provide insight into which services are likely to be in highest demand through 2013 and their intentions for sole provider partnerships.

Readers will gain an in-depth understanding of:

Report Content:

This report contains the following two sections.

Market Dynamics and Outsourcing Environment – This section discusses, from sponsors’ perspectives, which central labs services are likely to drive growth in the coming years; which global regions are increasing and decreasing in strategic importance; growth in “sole-provider” outsourcing; and sizes the market for outsourced central labs services.

Service Providers – This section provides an analysis of how central labs service providers are selected; how the top central labs providers perform, relative to their customers’ expectations; analyses of what drives satisfaction in central labs relationships; and central labs providers’ strengths and weaknesses; what can differentiate providers from each other; and the importance of specific metrics that labs providers might consider tracking and reporting going forward.

As always, ISR provides readers with a comprehensive Appendix of all charts and graphs for every question asked within this report.

What Readers Will Learn:

Service Providers will learn:

• Which attributes are most important to your customers when selecting a service provider 
• The market size for outsourced central lab services 
• The areas where sponsors see the most growth 
• Preferred provider, sole source, and regional pharma activity

Biopharmaceutical Companies will learn:

• How the top 7 service providers (Covance, Clearstone/ MDS, ICON, LabCorp, Quest, Quintiles) perform across key attributes 
• The views of your peers with regard to metrics usage and importance
• Your competitors’ adoption of sole source central lab partnerships